Companion Diagnostic Development & Validation
Pan-Cancer
Development/ValidationActive
Key Facts
About Pangaea Oncology
Pangaea Oncology is a private, revenue-generating company positioned as a precision oncology service provider and diagnostic developer in Southern Europe. Its core activities include a clinical reference laboratory offering comprehensive molecular diagnostics and companion diagnostics, and a preclinical services division (Pangaea Lab) specializing in biomarker discovery, organoid technology, and in-vitro testing. The company leverages its integrated clinical and R&D capabilities to serve both healthcare providers and pharmaceutical partners, with a strategic vision centered on data exploitation and AI to advance personalized cancer treatment.
View full company profileTherapeutic Areas
Other Pan-Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| Idylla POLE-POLD1 Mutation Assay | Biocartis | Research |
| Diagnostic Matching Service | DarwinHealth | Commercial |
| Platform-Driven Drug Discovery & Asset Prioritization | DarwinHealth | Discovery/Pre-clinical |
| af-003 | Alpha Fusion | IND-enabling |